I think when the market digests this it will re rate both companies .
Based on BD1 close up 5% it makes holding onto SDX shares even more attractive so I don’t think there will be to many SDX shares available and there will be demand for BD1 shares to get on this before the deal is completed. Big risk in SDX is if this falls over its hard to see the market keeping it up at 6 cents. You need a situation like the Bard 1 , complimentary technology and operating space, leverage of a move to East Coast, leverage of in market resources, combining good cash balances to make a deal like this work for both sides. I have thought SDX has been a sleeper for years and had almost given up on it ever waking up but this is the catalyst in needed. I think great news for BOTH companies.
Agree execution is key but some pretty seasoned players now involved.
- Forums
- ASX - By Stock
- SDX
- News: SDX Bard1 Life Sciences And Sienna Cancer Diagnostics Announce Merger
News: SDX Bard1 Life Sciences And Sienna Cancer Diagnostics Announce Merger, page-14
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SDX (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
UNT
UNITH LTD
Idan Schmorak, CEO
Idan Schmorak
CEO
Previous Video
Next Video
SPONSORED BY The Market Online